Safusidenib
Safusidenib is an orally bioavailable, mutant-selective IDH1 inhibitor with potent activity against IDH1R132H (IC50=15 nM) and IDH1R132C (IC50=130 nM) . It demonstrates antitumor efficacy in chondrosarcoma models and is a valuable tool for in vitro and in vivo research targeting IDH1-mutant cancers.
Product Specifications
CAS Number
1898206-17-1
Field of Research
Metabolism Research
Smiles
C (=O) (C=1C (=NOC1C (C) (C) F) C2=C (Cl) C=C (Cl) C=C2Cl) N3C=4C (C (C) =C3) =C (/C=C/C (O) =O) C=CC4
Molecular Formula
C25H18Cl3FN2O4
Molecular Weight
535.78
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
